
Researchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic reticulum (ER) stress response that is frequently hyperactivated in cancer and promotes survival of cancer cells during stressful conditions. The new compound has unique chemical properties that allow for precise activation and can be used for tracking its activity in vivo thanks to the emission of fluorescence.
Research was published online in the Journal of Medicinal Chemistry.
The ER is a cellular structure that oversees protein folding and assembly, and it activates stress response mechanisms in response to the accumulation of misfolded proteins or other stressful conditions, including low oxygen.
“Certain cancers rely on the protective role of the ER stress response to sustain their growth in stressful environmental conditions,” said Chih-Chi Andrew Hu, Ph.D., associate professor in Wistar’s Immunology, Microenvironment & Metastasis Program, and co-lead author on the study with Juan R. Del Valle, Ph.D., from the University of South Florida. “We and other groups showed that genetically and pharmacologically targeting the ER is a very effective way to attack various tumors.”
The Hu lab has been actively advancing a research program for development of compounds to block vital functions of the ER stress response, specifically inhibitors of the IRE1 protein that senses the ER stress and responds by activating a cascade of cellular events. In addition to inducing tumor cell apoptosis, these compounds activate antitumor T-cell function and inhibit tumor-associated immunosuppressive cells in vivo in mouse models, resulting in tumor shrinkage.
“This class of inhibitors has shown therapeutic promise in several cancer types, including chronic lymphocytic leukemia and Burkitt lymphoma,” said Hu. “Therefore, we are very interested in advancing them to the clinic.”
In this study, through a series of chemical modifications, Hu and collaborators created a molecule called PC-D-F07 that is pharmacologically inactive and requires UV irradiation to be “turned on” and converted into the active D-F07, which is a very potent inhibitor of IRE-1 function.
The novel prodrug strategy enhances the efficacy of IRE-1 inhibitors and allows fine control of their activity at a precise time and location by UV irradiation. Importantly, once active, D-F07 emits fluorescence that can be tracked in cells and potentially in vivo, providing a real-time therapy readout. This new strategy for stimulus-mediated release of pharmacological activity provides a promising platform to target the ER stress response for anticancer therapy and for developing other potent inhibitors.
Learn more: Enhanced Anticancer Compound May Allow for Precise Activation and Tracking of Treatment
The Latest on: Cancer treatment
[google_news title=”” keyword=”cancer treatment” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer treatment
- Puppy scam fools Council Bluffs cancer patienton July 25, 2024 at 1:45 am
An old, but ongoing scam continues to fool more victims. The latest to fall for it is a woman who doesn’t need more stress in her life by losing money. 6 News has another warning about puppy scams.
- 2 East Tennessee children cancer-free after months of treatment for rare eye canceron July 24, 2024 at 4:08 pm
KNOXVILLE, Tenn. — A Knoxville family is back home after their two children underwent months of cancer treatment in Pennsylvania. Earlier this year, Thomas and Vivienne Kneller were diagnosed with ...
- Tailoring Cancer Treatment to the Patient: The Importance of Biomarker Testing in Precision Medicineon July 24, 2024 at 7:31 am
Discover how precision medicine and immunotherapy are transforming cancer treatment by utilizing genetic profiling and advanced sequencing techniques to provide personalized, targeted care with fewer ...
- USC study explores at-home atezolizumab treatment for non-small cell lung cancer patientson July 24, 2024 at 7:03 am
LOS ANGELES (KABC) -- For many cancer patients, undergoing treatment means numerous trips to a hospital or clinic for several weeks. Each session could take hours. Now, in a first-of-its-kind study, ...
- Dear Doctor: What's the best treatment for colon cancer after surgery?on July 24, 2024 at 6:00 am
ANSWER: Surgery remains the primary way to cure colon cancer, which is why screening is so important. The sooner the cancer is found, the better.
- TV Judge Frank Caprio, 87, Does Push-Ups to Show His Strength After Cancer Treatment: 'I’m Back'on July 23, 2024 at 9:14 am
Judge Frank Caprio — star of the reality TV show 'Caught in Providence' — showed off his strength in an Instagram video after recovering from treatment for pancreatic treatment.
- Isabella Strahan Shares Emotional Brain Cancer Treatment Updateon July 23, 2024 at 5:30 am
Isabella Strahan’s latest vlog reveals that she is cancer-free eight months after being diagnosed with brain cancer. The milestone was bittersweet.
- 4 Easy-to-Make Recipes for During Cancer Treatment and Careon July 23, 2024 at 5:02 am
When going through cancer treatment, your appetite may be affected. You also may have side effects from chemotherapy or radiation. We’ve rounded up 4 recipes that you or your caretaker can whip up ...
- Budget 2024: Three Cancer Treatment Drugs Exempted From Customs Duty; What Does It Mean For the Patients?on July 23, 2024 at 1:09 am
Three cancer treatment medicines will be exempt from basic customs duty to make them more affordable, union Finance Minister Nirmala Sitharaman announced in her Budget 2024 presentation. Also, changes ...
- Known Biomarkers, Better Care: Optimizing a CDS Tool to Guide Personalized Cancer Treatmenton July 22, 2024 at 12:14 pm
Daniel Rubin, PharmD, discusses key takeaways from a study exploring the use. of a clinical decision tool for biomarker documentation.
via Bing News